The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program Pharmaceutical Investing
Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health Biotech Investing
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases Pharmaceutical Investing
AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meeting Pharmaceutical Investing
New Data Presented at the American College of Gastroenterology Annual Scientific Meeting Demonstrate Continuous Zeposia Treatment Prevents Disease Relapse Over One Year in 86.1% of Patients Who Respond at the End of the Induction Period Pharmaceutical Investing
Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities Pharmaceutical Investing
BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing Pharmaceutical Investing
U.S. Food and Drug Administration Accepts Supplemental New Drug Application for CAMZYOS® in Symptomatic Obstructive Hypertrophic Cardiomyopathy to Reduce the Need for Septal Reduction Therapy Pharmaceutical Investing
